Search Results - "Krabbe, L.M"

MSR150 Artificial Intelligence (AI) in Performing Landscape Review and Linguistic Analysis for Curative Intent in Prostate Cancer (PC) by Krabbe, L.M., Merseburger, A., Liew, A., Kurtyka, K., Panda, O., Dalechek, D., Heerdegen, A.C.S., Jain, R., De Solda, F., McCarthy, S.A., Brookman-May, S.D., Mundle, S.D., Yu Ko, W., Efstathiou, E.

Get full text

Novel classification for upper tract urothelial carcinoma to better risk-stratify patients eligible for kidney sparing strategies: an international collaborative study by Marcq, G., Foerster, B., Matin, S.F., Spiess, P., Bivalacqua, T., Wu, W., Rouprêt, M., Krabbe, L.M., Xylinas, E., Mir, C., Hendricksen, K., Mari, A., Egawa, S., Briganti, A., Moschini, M., Mathieu, R., Ku, J.H., Autorino, R., Heidenreich, A., Chlosta, P., Joniau, S., Pycha, A., D’andrea, D., Shariat, S.F., Kassouf, W., Wu, Wen-Jeng

Get full text

Outcome of papillary versus clear cell renal cell carcinoma varies significantly in non-metastatic disease by Wagener, N, Edelmann, D, Benner, A, Huck, N, Hutterer, G, Zigeuner, R, Borgmann, H, Haferkamp, A, Pahernik, S, Wolff, I, Krabbe, L.M, Herrmann, E, Vergho, D, Mirvald, C, Surcel, C, Musquera, M, Ecke, T, Prochazkova, K, Scavuzzo, A, Dell'Oglio, P, Capitanio, U, Klatte, T, Shariat, S, Zastrow, S, Wirth, M, Cindolo, L, May, M, Gilfrich, C, Stief, C, Brookman-May, S.D

Get full text

Does associated CIS with MIBC impact on neoadjuvant chemotherapy? Results of an International consortium by Vasdev, N, Zagar, H, Noel, J, Suleyman, N, Thorpe, A, Mir, M.C, Ercole, C.E, Zargar-Shoshtari, K, Fairey, A.S, Mertens, L.S, Dinney, C.P, Krabbe, L.M, Cookson, M.S, Jacobsen, N.E, Gandhi, N.M, Griffin, J, Montgomery, J.S, Yu, E.Y, Xylinas, E, Campain, N.J, Veeraterpillay, R, Kassouf, W, Dall’Era, M.A, Seah, J.A, Horenblas, S, Sridhar, S.S, McGrath, J.S, Aning, J, Shariat, S.F, Wright, J.L, Morgan, T.M, Holzbeierlein, J.M, Bivalacqua, T.J, North, S, Barocas, D.A, Lotan, Y, Garcia, J.A, Grivas, P, Shah, J.B, Van Rhijn, B.W, Daneshmand, S, Spiess, P.E, Li, J, Stephenson, A.J, Black, P

Get full text

650 A multi-institutional analysis of pathological and survival outcomes in patients with clinically node positive urothelial bladder cancer treated with neoadjuvant chemotherapy and radical cystectomy by Zargar-Shoshtari, K, Zargar, H, Fairey, A.S, Mertens, L.S, Dinney, C.P, Mir, M.C, Krabbe, L.M, Cookson, M.S, Jacobsen, N.E, Gandhi, N, Griffin, J, Montgomery, J.S, Vasdev, N, Yu, E.Y, Xylinas, E, Campain, N.J, Kassouf, W, Dall'Era, M.A, Seah, J.A, Ercole, C, Horenblas, S, Sridhar, S, McGrath, J.S, Aning, J, Shariat, S.F, Wright, J.L, Thorpe, A.C, Morgan, T.M, Holzbeierlein, J.M, Bivalacqua, T.J, North, S, Barocas, D.A, Lotan, Y, Garcia, J.A, Stephenson, A.J, Shah, J.B, Van Rhijn, B.W, Daneshmand, S, Spiess, P.E, Black, P

Get full text

Nomogram Predicting Bladder Cancer–specific Mortality After Neoadjuvant Chemotherapy and Radical Cystectomy for Muscle-invasive Bladder Cancer: Results of an International Consortium by Mir, Maria Carmen, Marchioni, Michele, Zargar, Homi, Zargar-Shoshtari, K., Fairey, A.S., Mertens, Laura S., Dinney, C.P., Krabbe, L.M., Cookson, M.S., Jacobsen, N.E., Griffin, J., Montgomery, J.S., Vasdev, N., Yu, E.Y., Xylinas, E., McGrath, J.S., Kassouf, W., Dall'Era, M.A., Sridhar, S.S., Aning, J., Shariat, S.F., Wright, J.L., Thorpe, A.C., Morgan, T.M., Holzbeierlein, J.M., Bivalacqua, T.J., North, S., Barocas, D.A., Lotan, Y., Grivas, P., Stephenson, A.J., Shah, J.B., van Rhijn, B.W., Spiess, P.E., Daneshmand, D., Black, P.C.

“…: Cisplatin-based neoadjuvant chemotherapy (NAC) for muscle-invasive bladder cancer (MIBC) is associated with improved overall and cancer-specific survival…”
Get full text

735 Nomogram predicting cancer specific mortality (CSM) after neoadjuvant chemotherapy and radical cystectomy for muscle-invasive bladder cancer (BC): Results of an international consortium by Mir, Maresma M.C, Ercole, E, Zargar, H, Espiritu, P.N, Fairey, A.S, Mertens, L.L.S, Dinney, C.P, Krabbe, L.M, Cookson, M.S, Jacobsen, N.E, Gandhi, N.M, Griffin, J, Montgomery, J.S, Vasdev, N, Yu, E.Y, Youseff, D, Xylinas, E, Campain, N.J, Kassouf, W, Dall'Era, M.A, Seah, J.A, Horenblas, S, Sridhar, S.S, McGrath, J.S, Aning, J, Shariat, S.F, Wright, J.L, Thorpe, A.C, Morgan, T.M, Holzbeierlein, J.M, Bivalacqua, T.J, North, S, Barocas, D.A, Lotan, Y, Garcia, J.A, Shah, J.B, Van Rhijn, B.W, Daneshmand, S, Spiess, P.E, Black, P.P.C, Stephenson, A.J

Get full text

Corrigendum to “Nomogram Predicting Bladder Cancer–specific Mortality After Neoadjuvant Chemotherapy and Radical Cystectomy for Muscle-invasive Bladder Cancer: Results of an International Consortium” [Eur Urol Focus 2021;7:1347–54] by Mir, Maria Carmen, Marchioni, Michele, Zargar, Homi, Zargar-Shoshtari, K., Fairey, A.S., Mertens, Laura S., Dinney, C.P., Krabbe, L.M., Cookson, M.S., Jacobsen, N.E., Griffin, J., Montgomery, J.S., Vasdev, N., Yu, E.Y., Xylinas, E., McGrath, J.S., Kassouf, W., Dall'Era, M.A., Sridhar, S.S., Aning, J., Shariat, S.F., Wright, J.L., Thorpe, A.C., Morgan, T.M., Holzbeierlein, J.M., Bivalacqua, T.J., North, S., Barocas, D.A., Lotan, Y., Grivas, P., Stephenson, A.J., Shah, J.B., van Rhijn, B.W., Spiess, P.E., Daneshmand, S., Black, P.C.

Get full text

646 - Outcome of papillary versus clear cell renal cell carcinoma varies significantly in non-metastatic disease by Wagener, N., Edelmann, D., Benner, A., Huck, N., Hutterer, G., Zigeuner, R., Borgmann, H., Haferkamp, A., Pahernik, S., Wolff, I., Krabbe, L.M., Herrmann, E., Vergho, D., Mirvald, C., Surcel, C., Musquera, M., Ecke, T., Prochazkova, K., Scavuzzo, A., Dell'Oglio, P., Capitanio, U., Klatte, T., Shariat, S., Zastrow, S., Wirth, M., Cindolo, L., May, M., Gilfrich, C., Stief, C., Brookman-May, S.D.

Get full text

896 - Does associated CIS with MIBC impact on neoadjuvant chemotherapy? Results of an International consortium by Vasdev, N., Zagar, H., Noel, J., Suleyman, N., Thorpe, A., Mir, M.C., Ercole, C.E., Zargar-Shoshtari, K., Fairey, A.S., Mertens, L.S., Dinney, C.P., Krabbe, L.M., Cookson, M.S., Jacobsen, N.E., Gandhi, N.M., Griffin, J., Montgomery, J.S., Yu, E.Y., Xylinas, E., Campain, N.J., Veeraterpillay, R., Kassouf, W., Dall’Era, M.A., Seah, J.A., Horenblas, S., Sridhar, S.S., McGrath, J.S., Aning, J., Shariat, S.F., Wright, J.L., Morgan, T.M., Holzbeierlein, J.M., Bivalacqua, T.J., North, S., Barocas, D.A., Lotan, Y., Garcia, J.A., Grivas, P., Shah, J.B., Van Rhijn, B.W., Daneshmand, S., Spiess, P.E., Li, J., Stephenson, A.J., Black, P.

Get full text

Systemische Behandlung des metastasierten Nierenzellkarzinoms: Paradigmenwechsel nach Einführung der zielgerichteten Therapie by Papavassilis, P., Krabbe, L.M., Thielen, B., Bögemann, M., Moritz, R., Hoffmeister, I., Hertle, L., Herrmann, E.

“…Zusammenfassung Hintergrund Unser Ziel war die Untersuchung des Therapiewandels beim metastasierten Nierenzellkarzinom (mNZK) seit 2006. Patienten und Methoden…”
Get full text